Stuart Packer
<p>Stuart Packer, MD, is a medical oncologist with extensive experience in treating lung, head and neck, prostate and other types of cancer. After graduating magna cum laude from Case Western Reserve University, Dr. Packer received his medical degree from the State University of New York/Downstate Medical Center. He went on to complete a residency in medicine and fellowship in hematology/medical oncology at Duke University Medical Center. Since then Dr. Packer has held clinical and teaching positions at leading cancer centers, including Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and Montefiore Einstein Center for Cancer Care.</p>
<p>Dr. Packer’s clinical expertise is in medical management of lung cancer, head and neck cancer and prostate cancer. He is director of the melanoma and sarcoma programs at Montefiore Einstein Center for Cancer Care. In addition, Dr. Packer is medical director of Montefiore’s Oncology Care Model (OCM), an alternative payment model sponsored by the Centers for Medicare and Medicaid Services and aimed at improving patient care coordination and appropriateness of care.</p>
<p>Dr. Packer is the author or co-author of medical textbook chapter and articles in peer-reviewed journals, including <em>Cancer, Clinical Cancer Research, British Medical Journal</em> and <em>Lung Cancer</em>. He is a member of the American Society of Clinical Oncology and the American Society of Hematology.</p>
Dr. Packer’s clinical expertise is in medical management of lung cancer, head and neck cancer and prostate cancer.
<p>Stuart Packer, MD, is a medical oncologist with extensive experience in treating lung, head and neck, prostate and other types of cancer. After graduating magna cum laude from Case Western Reserve University, Dr. Packer received his medical degree from the State University of New York/Downstate Medical Center. He went on to complete a residency in medicine and fellowship in hematology/medical oncology at Duke University Medical Center. Since then Dr. Packer has held clinical and teaching positions at leading cancer centers, including Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and Montefiore Einstein Center for Cancer Care.</p><p>Dr. Packer’s clinical expertise is in medical management of lung cancer, head and neck cancer and prostate cancer. He is director of the melanoma and sarcoma programs at Montefiore Einstein Center for Cancer Care. In addition, Dr. Packer is medical director of Montefiore's Oncology Care Model (OCM), an alternative payment model sponsored by the Centers for Medicare and Medicaid Services and aimed at improving patient care coordination and appropriateness of care.</p><p>Dr. Packer is the author or co-author of medical textbook chapter and articles in peer-reviewed journals, including <em>Cancer</em>, <em>Clinical Cancer Research</em>, <em>British Medical Journal</em> and <em>Lung Cancer</em>. He is a member of the American Society of Clinical Oncology and the American Society of Hematology.</p>
Jessica Pacifico
Sun Young Oh
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">The clinical focus is on medical oncology and the systemic treatment of breast cancer.</span>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Oh’s research follows her clinical focus and has been shared through publication in peer-reviewed journals.</span>
<p>Sun Young Oh, MD, is an Oncologist and Assistant Professor, Oncology and Medicine at Montefiore Einstein. Her clinical focus is on medical oncology and the systemic treatment of breast cancer.</p><p>In 2003, Dr. Oh completed her Doctor of Medicine at Ewha Womans University in Seoul, South Korea. She pursued postdoctoral training in the United States completing her internal medicine internship at Lutheran Medical Center in 2006, her internal medicine residency at Jacobi Medical Center/Albert Einstein College of Medicine in 2008 and her hematology and oncology fellowship at Tufts Medical Center/Tufts University School of Medicine in 2015.</p><p>Dr. Oh’s research follows her clinical focus and has been shared through publication in peer-reviewed journals.</p><p>Dr. Oh is board certified in internal medicine, medical oncology and hematology. She is a member of the American Society of Clinical Oncology</p>
Shrivatsa Nadiger
Howard S. Moskowitz
Clinical focus is on the medical and surgical treatment of ear and skull base disorders in adults and children, including chronic ear disease, hearing loss, dizziness, cochlear implants and ear and skull base tumors.<quillbot-extension-portal></quillbot-extension-portal>
Dr. Moskowitz’s research focuses on the development of novel treatments for skull base disorders, management of vestibular disorders, quality improvement in medical education and understanding the neural bases of auditory processing.<quillbot-extension-portal></quillbot-extension-portal>
<p>Howard S. Moskowitz, MD, PhD, is an attending physician and Associate Professor in the Department of Otorhinolaryngology–Head & Neck Surgery at Montefiore-Einstein. His clinical focus is on the medical and surgical treatment of ear and skull base disorders in adults and children, which includes chronic ear disease, hearing loss, dizziness, cochlear implants and tumors of the ear and skull base.</p><p>A graduate of Cornell University, Dr. Moskowitz received his Bachelor of Science in 1998. In 2005, he earned his Doctor of Philosophy at Weill Graduate School of Medical Sciences, followed by his Doctor of Medicine in 2006 at Weill Medical College. He began his postdoctoral training at the University of Pittsburgh Medical Center, completing his residency in otolaryngology–head & neck surgery in 2011. He then pursued a fellowship in otology, neurotology, and skull base surgery at Johns Hopkins Medical Institution, completing it in 2013.</p><p>Dr. Moskowitz’s research focuses on the development of novel treatments for skull base disorders, management of vestibular disorders, quality improvement in medical education and understanding the neural bases of auditory processing. His work has been published in numerous peer-reviewed journals, books and abstracts, as well as presented nationally.</p><p>He is board certified in otolaryngology–head & neck surgery and neurotology. In 2017, Dr. Moskowitz received the Teacher of the Year Award from the Department of Otorhinolaryngology–Head & Neck Surgery. He was named one of New York Super Doctors Rising Star Edition from 2015 to 2017. Dr. Moskowitz is board certified by the American Board of Otolaryngology and is a member of the American Academy of Otolaryngology–Head and Neck Surgery and the American Neurotology Society.</p>
Kerry A. Morrone
<p>Anemia, hospitalist medicine, general pediatrics</p>
Dr. Morrone focuses on classical hematology, particularly sickle cell disease and hemoglobinopathies, platelet disorders, thrombosis, and bone marrow failure syndromes.
Dr. Morrone is committed to improving quality of care and health care utilization in chronic illness, particularly sickle cell disease, and thalassemia through her research
<p>Kerry Morrone, MD, is an Assistant Professor of Pediatrics at the Albert Einstein College of Medicine, the Director of the Sickle Cell Program and the Director of the Pediatric Hematology Oncology Fellowship Program at Montefiore. Dr. Morrone focuses on classical hematology, particularly sickle cell disease and hemoglobinopathies, platelet disorders, thrombosis, and bone marrow failure syndromes.</p><p>Dr. Morrone graduated from New York University, earning her Bachelor of Arts in Biology in 2003. She then attended the Albert Einstein College of Medicine, where she received her Doctor of Medicine in 2007 and was inducted into the Alpha Omega Alpha Honor Medical Society. Dr. Morrone completed her pediatric residency, chief residency, and pediatric hematology oncology fellowship all at the Albert Einstein College of Medicine. She has also been recognized for her teaching efforts many times and won the Leo M. Davidoff Society – Albert Einstein College of Medicine Teaching Award in 2010 and 2015.</p><p>Dr. Morrone is committed to improving quality of care and health care utilization in chronic illness, particularly sickle cell disease, and thalassemia through her research. Other current research interests include pulmonary complications of sickle cell disease particularly asthma and acute chest syndrome, in addition to infectious complications and thrombotic complications of sickle cell disease.</p>
William B. Mitchell
<p>William Beau Mitchell, MD, is Director, Hemostasis and Thrombosis at the Children’s Hospital at Montefiore Einstein and Associate Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Mitchell’s clinical focus centers on pediatric hematology, particularly bleeding and clotting disorders, with a special interest and expertise in platelet disorders.</p><p>After earning his Doctor of Medicine at Tufts University School of Medicine in 1994, Dr. Mitchell completed a pediatric internship at Boston Medical Center in 1995, followed by his pediatric residency at the same institution in 1997. He then completed a fellowship in pediatric hematology oncology at Mount Sinai School of Medicine in 2001 and a research fellowship in the laboratory of blood and vascular biology at Rockefeller University in 2006.</p><p>Dr. Mitchell’s clinical research interests include novel therapies for rare blood disorders, hematological manifestations of disease, and transition from pediatric to adult care for patients with rare blood disorders. His basic science research interests include mechanisms of action of novel immune thrombocytopenia (ITP) therapies, platelet function in sickle cell disease, and the production of platelets from stem cells. Dr. Mitchell has been principal investigator and site principal investigator on a number of research projects, and he has given several national and international presentations. His work has been published in numerous peer-reviewed publications, books, chapters, and monographs, and he is an Associate Editor for Nature Pediatric Research. He is also a reviewer for many scientific journals, including the <em>Journal of Pediatrics: X</em>, <em>Pediatric Blood and Cancer</em> and the <em>Journal of Thrombosis and Haemostasis</em>.</p><p>Dr. Mitchell is board certified by the American Board of Pediatrics in Pediatrics and Pediatric Hematology Oncology. He is a member of the American Society of Hematology (ASH), the International Society for Hemostasis and Thrombosis (ISTH), and the American Society for Pediatric Hematology and Oncology (ASPHO). Dr. Mitchell has received two U.S. patents for his work in “Regulation of Integrin Surface Expression” and “Megakaryocyte and Platelet Production from Stem Cells.”</p>
Michael Miksa
Pediatric critical care
<p>Physician-Scientist, Michael Miksa, MD, PhD received his medical degree from the Free University of Berlin in Germany and his academic degree magna cum laude from The Charité – Universitätsmedizin Berlin. He completed his pediatric residency training at State University of New York (SUNY) Downstate, a critical care fellowship at Yale and had worked in the pediatric emergency department for the Boston Children’s Hospital.</p><p>Dr. Miksa presented his work at several meetings both nationally and abroad and is Site Investigator for NEAR4KIDS, a multi-center quality improvement study to limit adverse events during intubations.</p>